Trial intelligence / Profile preview

Fifteen Weisaierdou Pills for Chronic Cholecystitis

ChiCTR2000034477Phase 4Not yet recruiting

Sponsor
久美藏药
Start
Jul 2020
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of shiwuwei saierdou wan in chronic cholecystitis (2 arms), sponsored by 久美藏药. Primary endpoint: Hepatobiliary imaging changes. Planned start Jul 2020; status: not yet recruiting.

02

Drugs

shiwuwei saierdou wan
03

Conditions

chronic cholecystitis

Beyond the preview

Go deeper on ChiCTR2000034477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000034477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call